Key facts
- MACQUARIE GROUP LTD filed SCHEDULE 13G/A for Travere Therapeutics Inc Common Shares (TVTX).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2025.
MACQUARIE GROUP LTD - 31 Dec 2025 SCHEDULE 13G/A Report for Travere Therapeutics Inc Common Shares (TVTX)
- Filing Manager
- MACQUARIE GROUP LTD
- Reporting Manager
- Macquarie Group Limited
- Symbol
- TVTX
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 06:13:14 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Key filing fact
MACQUARIE GROUP LTD disclosed 0% ownership in Travere Therapeutics Inc Common Shares (TVTX) on 31 Dec 2025.
Change
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 13 Feb 2026, 06:13.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Macquarie Group Limited | 0% | 0 | 0 | 0 | /s/ Philip Alexander | Philip Alexander / Associate Director | |
| Macquarie Management Holdings Inc | 0% | 0 | 0 | 0 | /s/ Marty Wolin | Marty Wolin / Chief Compliance Officer | |
| Macquarie Investment Management Business Trust | 0% | 0 | 0 | 0 | /s/ Marty Wolin | Marty Wolin / Chief Compliance Officer |
CIK / CUSIP context first